Coloplast A/S (CLPBY)
12.41
+0.36
(+2.99%)
USD |
OTCM |
May 03, 16:00
Coloplast Debt to Equity Ratio: 1.372 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.372 |
| September 30, 2023 | 1.079 |
| June 30, 2023 | 3.270 |
| March 31, 2023 | 2.954 |
| December 31, 2022 | 3.611 |
| September 30, 2022 | 2.171 |
| June 30, 2022 | 2.733 |
| March 31, 2022 | 2.804 |
| December 31, 2021 | 0.6909 |
| September 30, 2021 | 0.2644 |
| June 30, 2021 | 0.5317 |
| March 31, 2021 | 0.5048 |
| December 31, 2020 | 0.6969 |
| September 30, 2020 | 0.15 |
| June 30, 2020 | 0.3953 |
| March 31, 2020 | 0.3972 |
| December 31, 2019 | 0.5483 |
| September 30, 2019 | 0.1542 |
| June 30, 2019 | 0.4782 |
| March 31, 2019 | 0.4186 |
| December 31, 2018 | 0.5853 |
| September 30, 2018 | 0.1966 |
| June 30, 2018 | 0.5719 |
| March 31, 2018 | 0.5921 |
| December 31, 2017 | 0.6145 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.2282 |
| June 30, 2017 | 0.5137 |
| March 31, 2017 | 0.5257 |
| December 31, 2016 | 0.6834 |
| September 30, 2016 | 0.0438 |
| June 30, 2016 | 0.2052 |
| March 31, 2016 | 0.0051 |
| December 31, 2015 | 0.0971 |
| September 30, 2015 | 0.0212 |
| June 30, 2015 | 0.1345 |
| March 31, 2015 | 0.0721 |
| December 31, 2014 | 0.068 |
| September 30, 2014 | 0.0146 |
| June 30, 2014 | 0.0284 |
| March 31, 2014 | 0.0222 |
| December 31, 2013 | 0.0212 |
| September 30, 2013 | 0.0164 |
| June 30, 2013 | 0.0237 |
| March 31, 2013 | 0.2065 |
| December 31, 2012 | 0.2255 |
| September 30, 2012 | 0.2145 |
| June 30, 2012 | 0.3955 |
| March 31, 2012 | 0.3833 |
| December 31, 2011 | 0.4716 |
| September 30, 2011 | 0.4704 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.15
Minimum
Sep 2020
3.611
Maximum
Dec 2022
1.306
Average
0.6909
Median
Dec 2021
Debt to Equity Ratio Benchmarks
| Genmab A/S | 0.00 |
| Ascendis Pharma A/S | -2.809 |
| Galecto Inc | -- |
| Evaxion Biotech AS | -1.825 |
| IO Biotech Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 7.214B |
| Total Liabilities (Quarterly) | 4.969B |
| Shareholders Equity (Quarterly) | 2.246B |
| Current Ratio | 0.5322 |
| Net Debt Paydown Yield | -0.54% |